ILDONG Pharmaceutical/Korea shall participate in CPhI SEA Booth No. B-41, Jakarta 20-22 May 2014

Ildong in partnership with Simanco at CPhI SEA 2014
Ildong in partnership with Simanco at CPhI SEA 2014

Korean pharmaceutical industry is known for their product quality and innovation; Ildong Pharmaceutical (Ildong) one Korea’s largest and wellknown pharmaceutical company shall participate in CPhI South-East Asia (SEA), Jakarta from 20-22 May 2014. Ildong’s overseas team left the CPhI SEA 2013 with lasting impression of Indonesian’s hospitality and customers’ interest to pursue partnership with Ildong. The booth will be located at B-41.

Having established longtime and close business partnership over the past decade, PT Sri Aman Corporindo (Simanco) is pleased to cooperate with Ildong to make the event successful for both parties.

Ildong was established in 1941 with a motto “Contributing to healthier and happier lives.” Ildong is the pioneer in probiotic product, their products such as Biovita and Aronamin are recognized as the leading brand in Korea. Ildong offer their customers with several services including Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulation (FDFs), and Technology Transfer (Tech-Transfer).

Simanco was established in 1968 with a motto “Your reliable mediator.” Simanco is actively engage in trade and distribution of raw material ingredients for pharmaceutical, cosmetic and Matricaria products, I for.

food industries in Indonesia. Simanco is supported by good network and business partner from India, Korea and China.

By participating in CPhI SEA, Ildong Pharmaceutical hopes that they could contribute a healthier and happier lives for Indonesian pharmaceutical industry, as stated in their motto. If you are interested to know further about Ildong Pharmaceutical and their services, you could contact us for further information and to schedule a fruitful meeting prior or during the exhibition. We are more than welcome if you have any inquiries. Thank you.

For more information please email: